Not known Factual Statements About Notoginsenoside R1
Usage of robust CYP1A2 inhibitors need to be discontinued just before initiating pirfenidone and averted during remedy; if potent CYP1A2 inhibitors are the only drug of selection, dosage reductions are recommendedUse of potent CYP1A2 inhibitors ought to be discontinued ahead of initiating remedy and averted all through treatment; if potent CYP1A2 i